Illumina Ventures

company

About

Illumina Ventures visions is to improve human health by unlocking the power of the genome.

  • 1 - 10

Details

Industries
Venture Capital
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
CVC,Venture Capital

Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. Illumina provides the majority of their capital and access to the expertise and vision of the world's leading genomics solutions provider.

They invest primarily in early stage companies, in areas where their expertise and special relationship with Illumina can add value. They typically syndicate with other leading institutional and strategic investors.

Focus areas include applications of genomics in life science research, healthcare, agriculture and environmental science, public safety and personal wellness.

Investments

Number of Investments
Number of Lead Investments
7
2
Illumina Ventures has made 7 investments. Their most recent investment was on Dec 19, 2022, when Protillion Biosciences raised $18M.
Date Company Name
Round Money Raised Industry Lead Investor
Series A $18M Biopharma Yes
Dec 5, 2022 SonoThera
Series A $60.75M Biopharma
Series B $80M Biotechnology
May 18, 2020 SQZ Biotech
Series D $65M Biotechnology
Aug 8, 2018 SQZ Biotech
Series C $72M Biotechnology